dataset · Mendeley Data
Analytical review of the Summary of Product Characteristics for drug with a Dutch Pharmacogeenetics Working Group (DPWG) Testing recommendation registered in Zimbabwe as of 1 February 2026. The SmPCs were systematically reviewed for pharmacogenomic information content and scored according to DPWG criteria fpr SmPC PGx information for clinical implication scoring. This is a pilot project of the Consortium for Genomics and Therapeutics in Africa (CGTA) to assess regulatory approved drug information.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.17632/8c3r52859h.1
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
